Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 1.00 |
| ▸ | CA4 | P22748 | 1/20 | 1.00 |
| ▸ | ENO1 | P06733 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | CASP3 | P42574 | 1/20 | 0.42 |
| ▸ | OTC | P00480 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | MME | P08473 | 2/20 | 0.39 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pala SCHEMBL59449 | 1.00 | CA2 (1.00) | CA2CA4ENO1MEN1LMNA | |
| Sparfosic Acid SCHEMBL31237824 | 0.98 | CA2 (0.96) | CA2CA4ENO1MEN1LMNA | |
| Pala SCHEMBL11121904 | 0.98 | CA2 (0.96) | CA2CA4ENO1MEN1LMNA | |
| Pala SCHEMBL31389020 | 0.98 | CA2 (0.96) | CA2CA4ENO1MEN1LMNA | |
| Pala SCHEMBL859680 | 0.98 | CA2 (0.96) | CA2CA4ENO1MEN1LMNA | |
| SCHEMBL7747522 | 0.85 | CA2 (0.74) | CA2CA4ENO1MEN1KMT2A | |
| Pala SCHEMBL3514468 | 0.85 | CA2 (0.72) | CA2CA4FOLH1OTC | |
| SCHEMBL3513056 | 0.84 | CA2 (0.71) | CA2CA4HPGDFOLH1GGH | |
| SCHEMBL12990268 | 0.84 | CA2 (0.71) | CA2CA4HPGDFOLH1GGH | |
| Sparfosic Acid SCHEMBL28558641 | 0.84 | CA2 (0.72) | CA2CA4ENO1MEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 333 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3441089-B1 | TREATMENT METHODS USING ADENOVIRUS | VASCULAR BIOGENICS LTD (IL) | 2022-12-14 | — | — | EP | claimed |
| EP-2714936-B1 | METHODS AND PRODUCTS FOR PRODUCING ENGINEERED MAMMALIAN CELL LINES WITH AMPLIFIED TRANSGENES | PREC BIOSCIENCES INC (US) | 2018-12-12 | — | — | EP | claimed |
| CN-108060164-A | A kind of siRNA for inhibiting RbAp48 genes and its prepare application in antineoplastic chemotherapy medicine sensitizer | 南方医科大学 | 2018-05-22 | — | — | CN | claimed |
| CN-102666536-B | 7-naphthyridine derivatives and the purposes as kinase inhibitor thereof | AETERNA ZENTARIS GMBH (DE) | 2016-03-30 | — | — | CN | claimed |
| WO-2026106969-A1 | NOVEL INHIBITORS OF INTERLEUKIN RECEPTOR- ASSOCIATED KINASE | UNIVERSITY OF ROCHESTER (US) | 2026-05-21 | — | — | WO | disclosed |
| US-12616678-B2 | Methods to of aldehyde dehydrogenases for treatment of cancer | THE PENN STATE RESEARCH FOUNDATION (PA) | 2026-05-05 | — | — | US | disclosed |
| EP-4724485-A1 | BACKPACKED-ANTIBODY CONSTRUCTS AND THEIR USES | Universidad del País Vasco/Euskal Herriko Unibertsitatea (ES) | 2026-04-15 | — | — | EP | disclosed |
| EP-3547831-B1 | HUMANIZED MOUSE MODEL WITH IMPROVED HUMAN INNATE IMMUNE CELL DEVELOPMENT | JACKSON LAB (US) | 2026-04-01 | — | — | EP | disclosed |
| EP-4706682-A2 | SMALL MOLECULE TRAIL GENE INDUCTION BY NORMAL AND TUMOR CELLS AS AN ANTICANCER THERAPY | The Penn State Research Foundation (US) | 2026-03-11 | — | — | EP | disclosed |
| EP-4706684-A2 | COMPOSITIONS AND METHODS FOR INCREASING THE EFFICACY OF IMMUNOTHERAPIES AND VACCINES | The Regents of The University of Michigan (US) | 2026-03-11 | — | — | EP | disclosed |
| US-20260062398-A1 | CANNABICHROMENE DERIVATIVES AND USE THEREOF | REMEDY PROCESSORS LLC (US) | 2026-03-05 | — | — | US | disclosed |
| US-20260061093-A1 | LIPID ANALOGS, LIPOSOMES COMPRISING SAME AND USES THEREOF | LIPOSPHERE LTD. (IL) | 2026-03-05 | — | — | US | disclosed |
| US-4730068-A | SPECIAL EFFECT ON BREAST CANCER | ASTA-WERKE AKTIENGESELLSCHAFT (DE) | 1988-03-08 | — | — | US | disclosed |
| US-4704464-A | CHELATE COMPOUNDS | ASTA-WERKE AKTIENGESELLSCHAFT CHEMISCHE FABRIK (DE) | 1987-11-03 | — | — | US | disclosed |
| EP-0116955-B1 | COMPLEXES OF (1,2-DIPHENYL-ETHYLENE DIAMINE) PLATINUM (II) | Degussa Aktiengesellschaft (DE) | 1987-05-20 | — | — | EP | disclosed |
| EP-0204989-A2 | Use of penicillamine in the treatment of immune deficiency diseases | ASTA Medica Aktiengesellschaft (DE) | 1986-12-17 | — | — | EP | disclosed |
| EP-0193083-A1 | Anti-tumoral(1-arylmethyl-ethylene diamine)-platinum(II)-complexes | ASTA Pharma AG (DE) | 1986-09-03 | — | — | EP | disclosed |
| EP-0193055-A1 | Antitumorals(1,2-diphenyl-ethylene diamine)-platinum (II) complexes | ASTA Pharma AG (DE) | 1986-09-03 | — | — | EP | disclosed |
| US-4598091-A | (1,2-diphenyl)-ethylenediamine)-platinum (II) complex compounds | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1986-07-01 | — | — | US | disclosed |
| EP-0116955-A2 | Complexes of (1,2-diphenyl-ethylene diamine) platinum (II) | Degussa Aktiengesellschaft (DE) | 1984-08-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062398-A1 | CANNABICHROMENE DERIVATIVES AND USE THEREOF | CTNND1, CNR2, CNR1 | CA2 3401/4885CA4 3248/4885ENO1 4851/4885 |
| US-20260061093-A1 | LIPID ANALOGS, LIPOSOMES COMPRISING SAME AND USES THEREOF | PHOSPHO1, SGMS1, SGMS2 | CA2 855/4885CA4 579/4885ENO1 2430/4885 |
| US-12616678-B2 | Methods to of aldehyde dehydrogenases for treatment of cancer | ALDH1A1, ALDH3A1, ADH1C | CA2 148/4885CA4 309/4885ENO1 1042/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.